|
1
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng
HX, Hu XX and Wang SK: MicroRNA expression profiles predict
progression and clinical outcome in lung adenocarcinoma. Onco
Targets Ther. 9:5679–5692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu X, Li S, Xu X, Wu S, Chen R, Jiang Q,
Li Y and Xu Y: The potential value of miR-1 and miR-374b as
biomarkers for colorectal cancer. Int J Clin Exp Pathol.
8:2840–2851. 2015.PubMed/NCBI
|
|
5
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Daniel R, Wu Q, Williams V, Clark G,
Guruli G and Zehner Z: A panel of MicroRNAs as diagnostic
biomarkers for the identification of prostate cancer. Int J Mol
Sci. 18(pii): E12812017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang YY, Kong LQ, Zhu XD, Cai H, Wang CH,
Shi WK, Cao MQ, Li XL, Li KS, Zhang SZ, et al: CD31 regulates
metastasis by inducing epithelial-mesenchymal transition in
hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway.
Cancer Lett. 429:29–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gramantieri L, Fornari F, Callegari E,
Sabbioni S, Lanza G, Croce CM, Bolondi L and Negrini M: MicroRNA
involvement in hepatocellular carcinoma. J Cell Mol Med.
12:2189–2204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Braconi C, Henry JC, Kogure T, Schmittgen
T and Patel T: The role of microRNAs in human liver cancers. Semin
Oncol. 38:752–763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greenhill C: Hepatocellular carcinoma: New
insight into angiogenesis in hepatocellular carcinoma: Involvement
of microRNA-26a. Nat Rev Gastroenterol Hepatol. 11:32014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q,
Yang W, Yao Y, Liu Q and Tu K: MicroRNA-212 suppresses tumor growth
of human hepatocellular carcinoma by targeting FOXA1. Oncotarget.
6:13216–13228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kurozumi A, Goto Y, Matsushita R, Fukumoto
I, Kato M, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa
T and Seki N: Tumor-suppressive microRNA-223 inhibits cancer
cell migration and invasion by targeting ITGA3/ITGB1
signaling in prostate cancer. Cancer Sci. 107:84–94. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu C, Ni Z, Li BS, Yong X, Yang X, Zhang
JW, Zhang D, Qin Y, Jie MM, Dong H, et al: hTERT promotes the
invasion of gastric cancer cells by enhancing FOXO3a ubiquitination
and subsequent ITGB1 upregulation. Gut. 66:31–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hunt S, Jones AV, Hinsley EE, Whawell SA
and Lambert DW: MicroRNA-124 suppresses oral squamous cell
carcinoma motility by targeting ITGB1. FEBS Lett. 585:187–192.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu
L, Tang X, Du YE, Hu P and Liu M: Twist induces
epithelial-mesenchymal transition and cell motility in breast
cancer via ITGB1-FAK/ILK signaling axis and its associated
downstream network. Int J Biochem Cell Biol. 71:62–71. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He B, Xiao YF, Tang B, Wu YY, Hu CJ, Xie
R, Yang X, Yu ST, Dong H, Zhao XY, et al: hTERT mediates gastric
cancer metastasis partially through the indirect targeting of ITGB1
by microRNA-29a. Sci Rep. 6:219552016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124, miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu XC, Dong QZ, Zhang XF, Deng B, Jia HL,
Ye QH, Qin LX and Wu XZ: microRNA-29a suppresses cell proliferation
by targeting SPARC in hepatocellular carcinoma. Int J Mol Med.
30:1321–1326. 2012. View Article : Google Scholar : PubMed/NCBI
|
